BACKGROUND: Metastatic @entity1745 is a disastrous consequence of @entity1149 ( @entity1149 ). There have been few studies of the outcomes or prognostic factors in @entity1 with metastatic @entity1745 from @entity1149 treated with surgery and adjuvant therapies. METHODS: From 2002 to 2013, 116 @entity1 with metastatic @entity1745 from @entity1149 treated with surgery and adjuvant therapies were enrolled in this retrospective analysis. Kaplan-Meier methods and Cox regression analysis were used to estimate overall survival and identify prognostic factors for survival. RESULTS: Multivariate analysis suggested that the Eastern Cooperative Oncology Group performance status (ECOG-PS), @entity86 , postoperative adjuvant radiation therapy, and target therapy were independent prognostic factors. Ninety @entity1 died at a median of twelve months (range, three to forty-seven months) postoperatively, and twenty-six @entity1 were still alive at the time of final follow-up (at a median of fifteen months [range, five to fifty-four months]). CONCLUSIONS: The @entity51 in spinal cord function after surgery was the most robust predictor of survival. Adjuvant radiation therapy and target therapy were also associated with a better prognosis. LEVEL OF EVIDENCE: Prognostic Level IV. See Instructions for Authors for a complete description of levels of evidence.

Metastatic Spinal Cord Compression from Non-Small-Cell Lung Cancer Treated with Surgery and Adjuvant Therapies: A Retrospective Analysis of Outcomes and Prognostic Factors in 116 XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1149 :: ('MESH:D002289', 'Disease') :: ['NSCLC', 'non-small-cell lung cancer'] @entity51 :: ('MESH:D009461', 'Disease') :: ['complete disappearance of deficits'] @entity1745 :: ('MESH:D013117', 'Disease') :: ['spinal cord compression'] @entity86 :: ('MESH:D019106', 'Disease') :: ['preoperative and postoperative Frankel scores']
@entity1 :: (9606,Species) :: ['Patients']
